Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Caleb Cheng

4PUBLICATIONS

27CO-AUTHORS

Molecular targetsSeparation technologiesProteins and peptides

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 12, 2025

Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.

Jean Ching-Yi Tien, Yali Zhai, Rong Wu

|Apr 24, 2025

Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.

Caleb Cheng, Jing Hu, Rahul Mannan

|Apr 01, 2024

Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.

Tongchen He, Caleb Cheng, Yuanyuan Qiao

|Aug 22, 2023

Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve.

Chungen Li, Yuanyuan Qiao, Xia Jiang

Pageof 1

Frequent Collaborators

3 joint publications

Zhen Wang

3 joint publications

Yuanyuan Qiao

3 joint publications

Rahul Mannan

3 joint publications

Arul M Chinnaiyan

2 joint publications

Ke Ding

2 joint publications

Rui Wang

2 joint publications

Costas A Lyssiotis

2 joint publications

Yuping Zhang

1 joint publications

Fengtao Zhou

1 joint publications

Yang Zhou

Frequent Collaborators

3 joint publications

Zhen Wang

3 joint publications

Yuanyuan Qiao

3 joint publications

Rahul Mannan

3 joint publications

Arul M Chinnaiyan

Top Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

Published on : Nov 28, 2010

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on : Jan 31, 2025

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

See more related videos

Top Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

Published on : Nov 28, 2010

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on : Jan 31, 2025

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

See more related videos